InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35
United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Atul Pande
28 Aug 2026
Director
Sold after exercise
1,500
$43.27
$64.91K
Atul Pande
24 Jul 2026
Director
Sold after exercise
1,500
$39.80
$59.70K
Atul Pande
26 Jun 2026
Director
Sold after exercise
1,500
$38.01
$57.02K
Tiago Girao
26 Jun 2026
Chief Financial Officer
Sold after exercise
10,000
$38.46
$384.60K
Tuyl Christopher Van
26 Jun 2026
Chief Legal Officer
Sold after exercise
2,842
$38.96
$110.72K
Tuyl Christopher Van
26 Jun 2026
Chief Legal Officer
Sold after exercise
14,982
$38.19
$572.16K
Atul Pande
15 Jun 2026
Director
Sold after exercise
1,500
$34.02
$51.03K
Andrew J. Fromkin
28 May 2026
Director
Sold after exercise
210,468
$33.56
$7.06M
Andrew J. Fromkin
28 May 2026
Director
Sold after exercise
11,483
$32.64
$374.81K
Atul Pande
20 May 2026
Director
Sold after exercise
6,000
$32.00
$192.00K
Show all 66 transactions →

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 10
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 2,029,785
History held since 15 May 2019